



　Immobilization is the most common orthopaedic 
treatment for musculoskeletal injury, deformity, 
and inflammation. After prolonged immobilization, 
however, complications such as joint contracture and 
atrophy of muscle and bone may occur1）. Physical 
therapy can prevent such joint contracture and disuse 
muscle atrophy, although the mechanisms responsible 
for this prevention remain uncertain.
　Previous studies have evidenced that experimental 
immobilization results in morphological degeneration 
in the soft tissues around articular joints1）, 2）. These 
changes seem to be related to joint contracture and 
muscle atrophy. However, little is known about how 
morphological changes are induced after immobilization 
in muscle. 
　Recently, several reports have suggested that loss 
of skeletal muscles can be attributed to multiple 
and complex proteolytic systems3-5）. The connective 
tissues surrounding the muscle fibers are broken 
down primarily by extracellular proteolytic systems 
such as matrix metalloproteinases （MMPs）6） and 
lysosomal proteases of invading macrophages4）, 7）. 
There also exist intracellular proteolytic systems, such 
as the ubiquitin-proteasome system8, 9）, intracellular 
lysosomal proteases, and calcium-dependent proteases 
（calpains）4）.
　In addition, the effects of physical therapy have 
been studied in mouse models of joint contracture and 
muscle atrophy in recent years10-12）. However, most of 
these studies have focused on morphological changes of 
skeletal muscles. Hurst et al. and Sasa et al. reported 
that continuous passive motion （CPM） was useful for 
the restoration of atrophied muscle in rats13, 14）. These 
reports suggested that CPM might be would be useful 
for preventing the disuse atrophy of muscle tissues 
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Abstract  We examined the effects of continuous passive motion （CPM） on membrane type 1-matrix 
metalloproteinase （MT1-MMP） expression in rat immobilized muscles. Eight-week-old male Wister rats 
were used for each of two trials, one with 2 weeks, and another one with 4 weeks of immobilization 
with/without CPM. In each trial, rats were immobilized （immobilization group）, and immobilized and 
simultaneously given CPM （CPM group）. The soleus muscle of each rat was evaluated by gelatin 
zymography, western blotting and reverse transcription-polymerase chain reaction （RT-PCR）. Gelatin 
zymography revealed a greater level of gelatinase activity in the extract of the muscles of the immobiliza-
tion group than in those of the control and CPM group. The expressions of matrix metalloproteinase 2 
（MMP-2） and MT1-MMP mRNA in the muscle extract of the immobilization group were also greater 
than those in the control and CPM group. Our results suggested that joint immobilization induces 
expression of MT1-MMP, a cleavage enzyme of MMP-2 in muscles, resulting in muscular degeneration, 
and that CPM can prevent these changes.




　In this study, we focused on the MMP activation 
network of the degradative process in muscle fibers 
of immobilized rats, and clarified the biochemical 




　Eight-week-old, male SPF Wister rats weighing 
200-300g were obtained from CLEA （Tokyo, Japan）. 
For each of the 2 immobilization trials, 20 of the rats 
were randomly divided into an immobilization group 
（n=10） and a CPM group （n=10）. After the each 
period, rats were anaesthetized （pentobarbital sodium 
40 mgkg-1） and soleous muscles were excised, snap 
frozen in liquid nitrogen and then stored at -80°C for 
subsequent analysis. All animals were maintained 
according the principles of laboratory animal care 
formulated by Nagasaki University （Japan） and the 
experimental procedures received approval from the 
Ethics Review Committee for Animal Experimentation 
of Nagasaki University. 
Immobilization
　Animals of both experimental groups were subjected 
to immobilization. After anesthetization with 
pentobarbital sodium （40mg/kg）, their right ankle 
joints were fixed in full planter flexion by plaster casts, 
with the soleus muscles immobilized in a shortened 
position. The plaster cast, which ran from above the 
knee joint to the distal foot, was changed weekly 
because of loosening due to muscle atrophy. The ankle 
joint was immobilized for 2, or 4 weeks, with 10 rats 
being used in each immobilization period. In addition, 
the left ankles of the rats in the immobilization group 
were used as controls.   
CPM
　Rats in the CPM group received CPM during the 
immobilization period. We performed CPM 6 times 
each week （Fig.1）. Briefly, the right hind foot was 
stretched maximally by dorsiflexing the ankle joints 
with angular velocities of 10 degrees/second using an 
ankle stretcher （Sakai Iryo Co., Ltd., Osaka, Japan） 
under anesthesia for 30min once a day. The range of 
the stretching was adjusted individually. We fixed the 
hip and knee joints of the rat and dorsiflexed the ankle 
joint. When resistance was felt, we determined the 
angle to the maximal dorsiflexing range of the ankle 
joint. Measurement of the range was defined as the 
angle （0-180 degrees） of a straight line connecting the 
5th metatarsal and malleolus lateralis of the fibula to 
a line connecting the malleolus lateralis of the fibula 
and the center of the knee joint when the ankle was 
passively dorsiflexed maximally. Both ankle joints of 
rats of the CPM group were fixed in full planter flexion 
by plaster cast except when CPM was performed.
Gelatin zymography
　At 2 and 4 weeks after immobilization, rats were 
anesthetized with pentobarbital sodium （40mg/kg）. 
The right soleus muscle was excised and muscle 
samples were randomly selected. Muscle samples were 
homogenized （1:7 v/w） in extraction buffer （100mM 
Trizma-HCl, pH7.6, 200mM MgCl2, 100mM CaCl2, 
and 0.1% TritonX-100） at 4°C. After centrifugation 
（15,000g）, the supernatant was divided into aliquots, 
and the protein concentration was determined by 
Bradford assay against a bovine albumin serum 
standard curve. Equal amounts of total protein （50μg/
lane） were electrophoresed on 8% polyacrylamide gels 
containing 1mg/ml gelatin at 4°C. After electrophoresis, 
the gels were washed in 2.5% Triton X-100 and incubated 
with 50mM Tris-HCl buffer （pH7.5） containing 0.15M 
NaCl, 10mM CaCl2 and 0.02% NaN3 for 16h at 37°C and 
stained with 0.1% Coomassie Brilliant Blue R250.
Immunoblot analysis
　An identical amount of proteins （100μg/lane） for 
each muscle extraction was subjected to 8% SDS-
PAGE. Proteins were transferred to nitrocellulose 
membranes. The filters were blocked for 1.5h using 
5% non-fat dried milk in Tris-buffered saline （TBS） 
containing 0.1% Tween 20 （TBS-T）, washed with 
TBS-T, and incubated at room temperature for 2h in 
a 1:200 dilution of rabbit anti-MT1-MMP monoclonal 
antibody or a 1:200 dilution of rabbit anti-Tissue 
inhibitor of metalloproteinases （TIMP）-1 monoclonal 
antibody. Filters were later washed with TBS-T and 
incubated with a 1:2000 dilution of donkey anti-rabbit 
Figure 1.
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IgG antibody, coupled with horseradish peroxidase. 
An enhanced chemiluminescence （ECL） system 
（Amersham） was used for detection. Filters were 
subsequently exposed to film for 15seconds and 
processed.
Reverse transcription polymerase chain reaction 
（RT-PCR） analysis
　Total RNA was extracted from each muscle using 
Isogen （Nippon Gene, Co., Ltd. Tokyo, Japan）. First-
strand cDNA was synthesized by reverse transcription 
at 37°C for 90min in a 20μl reaction mixture containing 
oligo dT primer by MuLV reverse transcriptase （Gibco 
BRL, Gaithersburg, MD） from 1μg of total RNA. After 
heating at 95°C for 5min to denature the proteins 
and cooling to 4°C, cDNA was amplified in a total 
volume of 20μl with 1U Taq DNA polymerase （Gibco 
BRL）, 1mM of both primers, and Taq polymerase 
buffer containing 1.5mM MgCl2 with 1.5mM of dNTP. 
PCR was carried out on a thermal cycler （Perkin 
Elmer Cetus） using a program of 30cycles （1min 
denaturation at 94°C, 1min annealing at 55°C, 1min 
elongation at 72°C and a final extension at 72°C for 10 
min）. The specific primers were as follows: for MMP-
2, 5’-GCTGATACTGACACTGGTACTG-3’ （sense） and 
5’-CAATCTTTTCTGGGAGCTC-3’ （antisense）, with 
a predicted fragment size of 217 bp; for MT1-MMP, 
5’-AGAGGGTCATTCATGGGCAG-3’ （sense） and 
5’-TCCCATGGCGTCTGAAGAAG-3’ （antisense）, with 
a predicted fragment size of 314 bp. After amplification, 
6μl of each PCR reaction mixture was subjected to 
electrophoresis on 1.5% （w/v） agarose gels with 
ethidium bromide （0.5mg/ml）.
Results
Detection of gelatinase activity
　We analyzed the gelatin-degrading activities in 
the muscles of three groups: the control （Fig.2a）, 
immobilization （Fig.2b）, and CPM （Fig.2c） groups. 
Gelatin zymography revealed the induction of 
gelatinase activity corresponding to an electrophoretic 
mobility of 66kDa. The 66kDa band was strongly 
induced in the immobilization group. In addition, 
gelatinolytic bands were detected beneath the 66kDa 
band in this lane. However, the induction of 66kDa 
and 62kDa bands was inhibited by CPM.
The expression of MMP-2 mRNA
　To examine the regulation of MMP-2 expression, we 
extracted the mRNA and evaluated the expressions of 
MMP-2 by RT-PCR. The expression of MMP-2 mRNA 
was induced in the immobilization group （Fig.3b）. 
However, the induction of MMP-2 expression was not 
detected in the control and CPM groups （Fig. 3c）.
The expression of MT1-MMP
　It has been reported that MT1-MMP induced the 
activation of MMP-215-17）. In this study, we examined 
the expression of MT1-MMP by western blotting. MT1-
MMP was induced in the immobilization group, but 
not in the CPM group （Fig.4b and c）.
The expression of MT1-MMP mRNA
　To examine the regulation of MT1-MMP expression, 
we extracted the mRNA and evaluated the expressions 
of MT1-MMP by RT-PCR. The expression of MT1-
MMP mRNA was induced in the immobilization 
group （Fig.5b）. However, the induction of MT1-MMP 
Figure 3.
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Figure 3.　Effect of immobilization and CPM on MMP-
2 mRNA expression of soleus muscle
　We analyzed the expression of MMP-2 mRNA using the 
RT-PCR technique in the muscles of the （a） control, （b） 
immobilization （2 weeks and 4 weeks）, and （c） CPM （2 
weeks and 4 weeks） groups.
Figure 2.
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Figure 2.　Effect of immobilization and CPM on 
gelatinolytic activity in soleus muscle
　We analyzed the gelatin-degrading activities in the muscles 
of the （a） control, （b） immobilization （2 weeks and 4 weeks）, 
and （c） CPM （2 weeks and 4 weeks） groups. ProMMP-2 was 
indicated as a 66kDa band. The active form of MMP-2 was 
detected under this band. 
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Figure 4.　Effect of immobilization and CPM on 
MT1-MMP expression in soleus muscle
　We analyzed the expression of MT1-MMP using western 
blot analysis in muscles of the （a） control, （b） immobilization 




expression was not detected in the control and CPM 
groups （Fig.5a and c）.
The expression of TIMP-1
　We also examined the expression of TIMP-1 by 
western blotting. The expression of TIMP-1 was induced 
in the immobilization group （Fig.6b）. However, the 
induction of TIMP-1 expression in the CPM group was 
almost the same as that in the immobilization group 
（Fig.6c）.
Discussion
　MMP-2 is one of proteolytic enzymes that play 
important roles in maintaining the structure and the 
activity of the basal lamina18）. MMP-2 is activated under 
various conditions such as chronic vasodilatation, 
innervation, and exercise19-23）. Our zymographic data 
show that rat MMP-2 was upregulated during the 
second week of limb immobilization in all three groups. 
MMP-2 is secreted by a wide range of connective tissue 
cells and is able to degrade many interstitial collagens 
（I-V）. Giannelli et al. identified the localization of 
MMP-2 in the endomysium and sarcolemma, and 
suggested that MMP-2 may act as interstitial 
collagenases in endomysial fibrosis and may be involved 
in muscle tissue remodeling or regeneration24）.
　We also examined the expression of MT1-MMP to 
clarify the activation process of MMP-2 in rat soleus 
muscles by immobilization. MT1-MMP is a 63kDa 
metalloproteinase, which has been shown to specifically 
induce the activation of pro-MMP-215-17）.
　It has also been reported that treatment with 
inflammatory cytokines induced MT1-MMP in human 
osteoarthritic cartilage25, 26）. Our results suggested 
that a novel role for the MMP-2 activation was 
possibly mediated by MT1-MMP in soleus muscles 
during immobilization. The activation of MMP-2 was 
correlated with the muscle degradation. We propose 
a potential mechanism for the pro-MMP-2 activation 
in muscle degeneration of disuse atrophy. In these 
muscles, pro-MMP-2 may be converted to the active 
form by expressing the MMP-2 activator, MT1-MMP, 
on the cell surface.
　The activities of MMPs are also under the control of 
enzyme tissue inhibitors of matrix metalloproteinases 
（TIMPs）27）. Western blot analysis of protein extracts 
demonstrated the expression of TIMP-1 in immobilized 
groups. A strong positive correlation between MMP-
2 and TIMP-1 has recently been reported in bovine 
skeletal muscle27）. Also, intense TIMP-1 staining 
surrounding individual myofibers and in the adjacent 
connective tissue and surrounding blood vessels has 
recently been described in abnormal human masseter 
muscle.21） 
　Our results showed that CPM inhibited the 
activation of MMP-2, together with the inhibition of 
MT1-MMP activation at both the protein level and 
mRNA level. Although CPM prevented the expression 
of both MMP-2 and MT1-MMP, it did not influence the 
expression of TIMP-1. It is likely that CPM corrected 
the increased expression of MMPs while maintaining 
the balance with TIMP, and this slowed the progression 
of proteolysis. Giannelli et al. suggested that muscle 
disuse induced a proteolytic imbalance of MMPs, which 
could be responsible for the breakdown of basal lamina 
structures, and that this led to an altered permeability, 
which could explain the reduced diameter of the soleus 
fibers and the reduced protein concentrations18）. 
　The nutrient and oxygen supply of muscles was 
promoted by adequate exercise, which improved the 
flow in the muscle microenvironment, and led to a 
decline in MMP-2 activation and other degeneration 
processes. Moreover, the inhibition of the activation of 
MMP-2 would prevent the degradation of ECM. In this 
way the viability of the capillaries was protected, and 
the microenvironment was maintained, which led to 
prevention of the degeneration process in the muscles 
and surrounding ECM. 
Figure 5.　Effect of immobilization and CPM on MT1-
MMP mRNA expression in soleus muscle
　We analyzed the expression of MT1-MMP mRNA using 
RT-PCR technique in muscles of the （a） control, （b） 
immobilization （2 weeks and 4 weeks）, and （c） CPM （2 
weeks and 4 weeks） groups.
Figure 6.　Effect of immobilization and CPM on
 TIMP-1 expression of soleus muscle
　We analyzed the expressi]n of TIMP-1 using western blot in 
muscles of the （a） control, （b） immobilization （2 weeks and 
4 weeks）, and （c） CPM （2 weeks and 4 weeks） groups.
Figure 5.
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　We concluded that joint immobilization induced the 
activation of matrix metalloproteinases, including 
MT1-MMP, and thereby resulted in degeneration and 
atrophy of muscle fibrils, and that CPM as a useful 
technique for preventing these changes.
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